What does the evidence say about Niacinamide Skin Health Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Niacinamide Skin Health Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Neutral donor pH (7.4) increased NIA permeation by roughly twofold compared with acidic pH (5.0) in both membrane types. [Sjöberg T (2026); evidence level 4] - Correspondingly, pH 7.4 decreased R mem and increased C eff , indicating pH driven changes in SC lipid organization and dielectric behavior. [Sjöberg T (2026); evidence level 4] - In conclusion, donor phase pH is a critical determinant of NIA skin permeation, primarily through reversible modulation of SC lipid structure and transport pathways. [Sjöberg T (2026); evidence level 4] - Niacinamide (NIA) is a widely used skincare ingredient with established benefits for skin barrier support, inflammation reduction, and dermal health. [Sjöberg T (2026); evidence level 4] - Rheological measurements showed that the storage modulus ( G ') increased from 1795 Pa (Gel) to 4699 Pa (NTp-Gel), indicating improved mechanical strength. [Xiong Z (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.